1. |
Cassidy SB, Schwartz S, Miller JL, et al. Prader-Willi syndrome. Genet Med, 2012, 14(1): 10-26.
|
2. |
Emerick JE, Vogt KS. Endocrine manifestations and management of Prader-Willi syndrome. Int J Pediatr Endocrinol, 2013, 2013(1): 14.
|
3. |
Angulo MA, Butler MG, Cataletto ME. Prader-Willi syndrome: a review of clinical, genetic, and endocrine findings. J Endocrinol Invest, 2015, 38(12): 1249-1263.
|
4. |
Nakamura Y, Murakami N, Iida T, et al. The characteristics of scoliosis in Prader-Willi syndrome (PWS): analysis of 58 scoliosis patients with PWS. J Orthop Sci, 2015, 20(1): 17-22.
|
5. |
Nagai T, Obata K, Ogata T, et al. Growth hormone therapy and scoliosis in patients with Prader-Willi syndrome. Am J Med Genet A, 2006, 140(15): 1623-1627.
|
6. |
Alves C, Franco RR. Prader-Willi syndrome: endocrine manifestations and management. Arch Endocrinol Metab, 2020, 64(3): 223-234.
|
7. |
Odent T, Accadbled F, Koureas G, et al. Scoliosis in patients with Prader-Willi Syndrome. Pediatrics, 2008, 122(2): e499-e503.
|
8. |
Oore J, Connell B, Yaszay B, et al. Growth friendly surgery and serial cast correction in the treatment of early-onset scoliosis for patients with Prader-Willi syndrome. J Pediatr Orthop, 2019, 39(8): e597-e601.
|
9. |
Accadbled F, Odent T, Moine A, et al. Complications of scoliosis surgery in Prader-Willi syndrome. Spine (Phila Pa 1976), 2008, 33(4): 394-401.
|
10. |
Nakamura Y, Nagai T, Iida T, et al. Growth hormone supplement treatment reduces the surgical risk for Prader-Willi syndrome patients. Eur Spine J, 2012, 21(Suppl 4): S483-S491.
|
11. |
杜悠, 仉建国. Prader-Willi综合征合并脊柱侧凸的病因、特点及治疗. 中华骨与关节外科杂志, 2020, 13(9): 772-777.
|
12. |
Muscogiuri G, Formoso G, Pugliese G, et al. Prader- Willi syndrome: an uptodate on endocrine and metabolic complications. Rev Endocr Metab Disord, 2019, 20(2): 239-250.
|
13. |
Eiholzer U, Whitman BY. A comprehensive team approach to the management of patients with Prader-Willi syndrome. J Pediatr Endocrinol Metab, 2004, 17(9): 1153-1175.
|
14. |
Khan MJ, Gerasimidis K, Edwards CA, et al. Mechanisms of obesity in Prader-Willi syndrome. Pediatr Obes, 2018, 13(1): 3-13.
|
15. |
Abdilla Y, Andria BM, Calleja-Agius J. Prader-Willi syndrome: background and management. Neonatal Netw, 2017, 36(3): 134-141.
|
16. |
Crino A, Fintini D, Bocchini S, et al. Obesity management in Prader-Willi syndrome: current perspectives. Diabetes Metab Syndr Obes, 2018, 11: 579-593.
|
17. |
Chung MS, Langouet M, Chamberlain SJ, et al. Prader-Willi syndrome: reflections on seminal studies and future therapies. Open Biol, 2020, 10(9): 200195.
|
18. |
中华医学会医学遗传学分会遗传病临床实践指南撰写组, 李川, 谢波波, 等. Prader-Willi综合征的临床实践指南. 中华医学遗传学杂志, 2020, 37(3): 318-323.
|
19. |
Miller JL, Tan M. Dietary management for adolescents with Prader-Willi syndrome. Adolesc Health Med Ther, 2020, 11: 113-118.
|
20. |
Kopel J. Diagnostic and prognostic problems with the Prader-Willi syndrome. Proc (Bayl Univ Med Cent), 2019, 32(1): 167-168.
|
21. |
Anglin K. Prader-Willi syndrome 101: an overview for pediatric nurses. J Pediatr Nurs, 2017, 36: 263-264.
|